|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_ocn948296969 |
| 003 |
OCoLC |
| 005 |
20231120112106.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
160429s2016 enk o 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d IDEBK
|d OPELS
|d N$T
|d YDXCP
|d OCLCF
|d EBLCP
|d UPM
|d MERUC
|d OCLCQ
|d U3W
|d D6H
|d WYU
|d LQU
|d OCLCQ
|d UKMGB
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBB663580
|2 bnb
|
| 016 |
7 |
|
|a 017837043
|2 Uk
|
| 019 |
|
|
|a 950464387
|a 1066463042
|a 1105175328
|a 1105565119
|
| 020 |
|
|
|a 9780323389600
|q (electronic bk.)
|
| 020 |
|
|
|a 0323389600
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323389457
|q (print)
|
| 035 |
|
|
|a (OCoLC)948296969
|z (OCoLC)950464387
|z (OCoLC)1066463042
|z (OCoLC)1105175328
|z (OCoLC)1105565119
|
| 050 |
|
4 |
|a TA418.9.N35
|
| 072 |
|
7 |
|a TEC
|x 009000
|2 bisacsh
|
| 072 |
|
7 |
|a TEC
|x 035000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 620.1/15
|2 23
|
| 245 |
0 |
0 |
|a Boron nitride nanotubes in nanomedicine /
|c edited by Gianni Ciofani, Virgilio Mattoli.
|
| 264 |
|
1 |
|a Oxford, UK :
|b William Andrew is an imprint of Elsevier,
|c 2016.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Micro and nano technologies
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed May 9, 2016).
|
| 505 |
0 |
|
|a Cover; Titile Page; Copyright Page; Contents; List of Contributors; Biographies; Foreword; Chapter 1 -- Introduction to boron nitride nanotubes: synthesis, properties, functionalization, and cutting; 1.1 -- Introduction; 1.2 -- Properties of BNNTs for potential biomedical applications; 1.3 -- Synthesis of BNNTs; 1.3.1 -- Chemical vapor deposition; 1.3.2 -- Ball milling; 1.3.3 -- Laser-based techniques; 1.3.4 -- Large-scale synthesis by plasma-based techniques; 1.4 -- Comparison of production rate, purity, and dispersibility of BNNTs.
|
| 505 |
8 |
|
|a 1.5 -- Functionalization and cutting of BNNTs for biomedical applications1.5.1 -- Noncovalent functionalization; 1.5.2 -- Covalent functionalization; 1.6 -- Summary; Acknowledgments; References; Chapter 2 -- Functionalization of boron nitride nanotubes for applications innanobiomedicine; 2.1 -- Introduction; 2.2 -- Covalent functionalization; 2.2.1 -- Nitrogen site reaction; 2.2.2 -- Boron site reaction; 2.3 -- Noncovalent functionalization; 2.3.1 -- Small molecules with aromatic groups; 2.3.2 -- Small molecules without aromatic groups; 2.3.3 -- Amino acids; 2.3.4 -- Surfactants; 2.3.5 -- Peptides.
|
| 505 |
8 |
|
|a 2.3.6 -- Deoxyribonucleic acids (DNA)2.3.7 -- Lipids; 2.3.8 -- Polysaccharides; 2.3.9 -- Polymers; 2.4 -- Defect reaction approach; 2.5 -- Filling BNNTs approach; 2.6 -- Conclusions and perspectives; References; Chapter 3 -- Biocompatibility evaluation of boron nitride nanotubes; 3.1 -- Introduction; 3.2 -- Common methods for evaluating in vitro biocompatibility; 3.2.1 -- Viability and cytotoxicity assays; 3.2.2 -- ROS detection; 3.2.3 -- Apoptosis and necrosis detection; 3.2.4 -- Genotoxicity assessment; 3.3 -- In vitro biocompatibility assessment; 3.4 -- In vivo biocompatibility assessment.
|
| 505 |
8 |
|
|a 3.5 -- Future studies and perspectives3.6 -- Conclusions; References; Chapter 4 -- Theoretical investigations of interactions between boron nitride nanotubes and drugs; 4.1 -- Introduction; 4.2 -- Density functional theory methods; 4.3 -- BNNTs/biomolecules interactions; 4.3.1 -- BNNTs and platinum-based drugs; 4.3.2 -- BNNTs and heterocyclic compound; 4.3.3 -- BNNTs and other clinically-relevant molecules; 4.3.4 -- BNNTs and amino acids; 4.4 -- Conclusions; References; Chapter 5 -- Boron nitride nanotubes as drug carriers; 5.1 -- Introduction.
|
| 505 |
8 |
|
|a 5.2 -- Improving the dispersibility of BNNT-based drug carriers5.2.1 -- Oxidation method; 5.2.2 -- Polymer surface modification method; 5.2.3 -- Plasma treatment; 5.2.4 -- Mesoporous silica coating method; 5.3 -- Various drug molecules loaded onto BNNT-based drug carriers; 5.3.1 -- DNA; 5.3.2 -- Proteins; 5.3.3 -- Flavin mononucleotide; 5.3.4 -- Chemotherapy drugs; 5.4 -- Interactions between BNNTs and drug molecules; 5.4.1 -- Weak interactions; 5.4.2 -- Covalent interactions; 5.5 -- Integration of multifunctional properties in BNNT-BASED drug carriers; 5.5.1 -- Targeting release; 5.5.2 -- Imaging.
|
| 505 |
8 |
|
|a 5.5.3 -- Acting as B carrier for boron neutron capture therapy.
|
| 650 |
|
0 |
|a Nanotubes.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
2 |
|a Nanotubes
|0 (DNLM)D043942
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Nanotubes.
|0 (CaQQLa)201-0364145
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Engineering (General)
|2 bisacsh
|
| 650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Reference.
|2 bisacsh
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 650 |
|
7 |
|a Nanotubes
|2 fast
|0 (OCoLC)fst01032640
|
| 700 |
1 |
|
|a Ciofani, Gianni,
|e editor.
|
| 700 |
1 |
|
|a Mattoli, Virgilio,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|a Ciofani, Gianni.
|t Boron Nitride Nanotubes in Nanomedicine.
|d : Elsevier Science, �2016
|z 9780323389457
|
| 830 |
|
0 |
|a Micro & nano technologies.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323389457
|z Texto completo
|
